Healthcare Sector Stocks
The Healthcare sector has a total of 1060 stocks, with a combined market cap of $9.31 trillion, total revenue of $4.66 trillion and a weighted average PE ratio of 49.77.
Market Cap
9.31T
Revenue
4.66T
Profits
187.13B
PE Ratio
49.77
Profit Margin
4.01%
Dividend Yield
0.38%
1060 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 1.09T | 0.43% | 1,353,325 | 79.67B |
| 2 | JNJ | Johnson & Johnson | 628.91B | 0.45% | 2,779,606 | 97.93B |
| 3 | ABBV | AbbVie Inc. | 439.94B | -0.45% | 2,472,630 | 64.39B |
| 4 | UNH | UnitedHealth Group Incorporated | 364.45B | 0.95% | 2,365,560 | 450.13B |
| 5 | MRK | Merck & Co., Inc. | 328.63B | 2.13% | 7,763,133 | 66.57B |
| 6 | NVS | Novartis AG | 294.87B | -1.29% | 2,146,746 | 56.69B |
| 7 | AZN | AstraZeneca PLC | 245.13B | -0.42% | 3,250,638 | 61.37B |
| 8 | AMGN | Amgen Inc. | 224.94B | 0.42% | 1,099,795 | 38.10B |
| 9 | TMO | Thermo Fisher Scientific Inc. | 223.20B | -0.22% | 1,061,542 | 46.34B |
| 10 | NVO | Novo Nordisk A/S | 209.73B | -1.54% | 7,447,501 | 50.34B |
| 11 | ABT | Abbott Laboratories | 191.88B | 1.07% | 4,605,875 | 46.59B |
| 12 | GILD | Gilead Sciences, Inc. | 168.32B | -0.01% | 3,635,214 | 30.46B |
| 13 | PFE | Pfizer Inc. | 149.87B | -1.22% | 25,058,152 | 63.70B |
| 14 | DHR | Danaher Corporation | 145.36B | -0.32% | 1,942,485 | 25.11B |
| 15 | ISRG | Intuitive Surgical, Inc. | 141.56B | -0.13% | 2,478,202 | 11.03B |
| 16 | VRTX | Vertex Pharmaceuticals Incorporated | 133.21B | -0.77% | 667,472 | 12.59B |
| 17 | SYK | Stryker Corporation | 133.02B | -0.39% | 1,493,925 | 25.84B |
| 18 | BMY | Bristol-Myers Squibb Company | 130.37B | 0.33% | 5,263,277 | 49.19B |
| 19 | CVS | CVS Health Corporation | 121.29B | 1.43% | 3,767,215 | 412.65B |
| 20 | MDT | Medtronic plc | 116.22B | 0.12% | 4,697,105 | 36.36B |
| 21 | SNY | Sanofi | 104.29B | 0.46% | 2,386,243 | 55.89B |
| 22 | MCK | McKesson Corporation | 102.26B | -2.74% | 812,657 | 410.98B |
| 23 | GSK | GSK plc | 101.15B | -1.26% | 3,387,016 | 44.05B |
| 24 | HCA | HCA Healthcare, Inc. | 89.91B | 0.94% | 777,338 | 78.01B |
| 25 | ELV | Elevance Health, Inc. | 86.24B | 1.86% | 419,768 | 201.11B |
| 26 | REGN | Regeneron Pharmaceuticals, Inc. | 79.31B | -0.34% | 319,850 | 15.53B |
| 27 | BSX | Boston Scientific Corporation | 74.53B | 0.47% | 15,681,527 | 21.00B |
| 28 | CI | The Cigna Group | 73.51B | 1.58% | 947,247 | 282.38B |
| 29 | COR | Cencora, Inc. | 59.87B | -6.03% | 1,739,716 | 332.77B |
| 30 | TAK | Takeda Pharmaceutical Company Limited | 55.76B | -0.46% | 1,672,294 | 28.42B |
| 31 | CAH | Cardinal Health, Inc. | 54.52B | -2.43% | 1,163,095 | 254.25B |
| 32 | ARGX | argenx SE | 54.05B | 0.74% | 132,107 | 5.32B |
| 33 | EW | Edwards Lifesciences Corporation | 53.71B | -0.51% | 1,537,034 | 6.51B |
| 34 | BDX | Becton, Dickinson and Company | 49.88B | 0.94% | 897,337 | 22.48B |
| 35 | MDLN | Medline Inc. | 46.78B | 1.56% | 4,642,290 | 29.94B |
| 36 | HUM | Humana Inc. | 46.48B | 3.82% | 796,584 | 145.68B |
| 37 | NTRA | Natera, Inc. | 45.39B | 0.69% | 602,919 | 2.71B |
| 38 | IDXX | IDEXX Laboratories, Inc. | 45.06B | -2.50% | 270,763 | 4.55B |
| 39 | RVMD | Revolution Medicines, Inc. | 43.74B | -0.72% | 831,408 | - |
| 40 | TEVA | Teva Pharmaceutical Industries Limited | 42.96B | 1.07% | 4,349,861 | 17.32B |
| 41 | HLN | Haleon plc | 42.82B | -1.11% | 4,049,411 | 14.80B |
| 42 | A | Agilent Technologies, Inc. | 41.94B | -0.68% | 815,781 | 7.23B |
| 43 | ONC | BeOne Medicines AG | 40.77B | -0.18% | 258,091 | 6.13B |
| 44 | WAT | Waters Corporation | 40.70B | -0.17% | 488,785 | 4.64B |
| 45 | IQV | IQVIA Holdings Inc. | 40.00B | -0.33% | 533,030 | 16.98B |
| 46 | VEEV | Veeva Systems Inc. | 39.13B | 1.81% | 1,304,694 | 3.32B |
| 47 | ALC | Alcon Inc. | 36.38B | -2.24% | 2,479,598 | 10.86B |
| 48 | DXCM | DexCom, Inc. | 34.31B | 1.56% | 3,991,496 | 4.97B |
| 49 | RPRX | Royalty Pharma plc | 33.93B | 2.11% | 2,713,299 | 2.54B |
| 50 | CNC | Centene Corporation | 33.19B | 3.55% | 2,087,172 | 180.30B |
| 51 | GEHC | GE HealthCare Technologies Inc. | 32.69B | -0.51% | 1,985,000 | 21.27B |
| 52 | RMD | ResMed Inc. | 32.59B | 0.48% | 877,251 | 5.65B |
| 53 | BIIB | Biogen Inc. | 30.83B | 2.34% | 493,993 | 10.03B |
| 54 | ZTS | Zoetis Inc. | 30.35B | -2.52% | 5,806,950 | 9.53B |
| 55 | ALNY | Alnylam Pharmaceuticals, Inc. | 29.81B | 0.70% | 821,822 | 4.80B |
| 56 | ILMN | Illumina, Inc. | 28.96B | -0.55% | 852,130 | 4.49B |
| 57 | INSM | Insmed Incorporated | 28.86B | -0.31% | 1,180,105 | 1.14B |
| 58 | MTD | Mettler-Toledo International Inc. | 28.85B | 0.20% | 96,973 | 4.13B |
| 59 | PHG | Koninklijke Philips N.V. | 26.56B | -0.85% | 552,446 | 20.18B |
| 60 | DGX | Quest Diagnostics Incorporated | 26.30B | 0.35% | 409,816 | 11.56B |
| 61 | LH | Labcorp Holdings Inc. | 26.23B | 0.30% | 235,756 | 14.35B |
| 62 | ROIV | Roivant Sciences Ltd. | 25.97B | 1.99% | 3,671,904 | 7.53M |
| 63 | MRNA | Moderna, Inc. | 25.36B | 4.88% | 4,535,250 | 2.23B |
| 64 | WST | West Pharmaceutical Services, Inc. | 24.81B | 0.34% | 165,749 | 3.33B |
| 65 | INCY | Incyte Corporation | 24.47B | -0.31% | 683,281 | 5.82B |
| 66 | BNTX | BioNTech SE | 23.43B | 0.53% | 389,554 | 3.03B |
| 67 | STE | STERIS plc | 23.10B | -0.53% | 448,061 | 6.04B |
| 68 | GH | Guardant Health, Inc. | 22.14B | -0.06% | 844,204 | 1.18B |
| 69 | UTHR | United Therapeutics Corporation | 21.83B | -1.26% | 221,851 | 3.15B |
| 70 | THC | Tenet Healthcare Corporation | 21.50B | 2.92% | 366,017 | 21.81B |
| 71 | GMAB | Genmab A/S | 18.77B | 1.70% | 2,958,458 | 4.13B |
| 72 | ZBH | Zimmer Biomet Holdings, Inc. | 18.53B | -0.10% | 1,610,947 | 8.51B |
| 73 | VTRS | Viatris Inc. | 18.52B | -0.98% | 5,422,712 | 14.74B |
| 74 | ASND | Ascendis Pharma A/S | 16.87B | 0.53% | 286,463 | 998.25M |
| 75 | MEDP | Medpace Holdings, Inc. | 16.69B | -1.25% | 217,990 | 2.78B |
| 76 | BBIO | BridgeBio Pharma, Inc. | 16.31B | -0.35% | 1,404,021 | 713.07M |
| 77 | JAZZ | Jazz Pharmaceuticals plc | 16.16B | 0.36% | 403,261 | 4.60B |
| 78 | NBIX | Neurocrine Biosciences, Inc. | 15.91B | -3.36% | 1,680,404 | 3.37B |
| 79 | COO | The Cooper Companies, Inc. | 14.99B | 0.04% | 2,026,789 | 4.23B |
| 80 | SOLV | Solventum Corporation | 14.54B | 1.55% | 515,424 | 8.31B |
| 81 | BAX | Baxter International Inc. | 14.00B | -1.92% | 4,567,382 | 11.47B |
| 82 | CRL | Charles River Laboratories International, Inc. | 13.67B | 1.58% | 720,258 | 4.00B |
| 83 | BMRN | BioMarin Pharmaceutical Inc. | 13.61B | 1.06% | 2,143,216 | 3.41B |
| 84 | RVTY | Revvity, Inc. | 13.09B | 1.37% | 702,540 | 2.91B |
| 85 | ICLR | ICON Public Limited Company | 12.89B | 0.92% | 456,574 | 8.29B |
| 86 | PEN | Penumbra, Inc. | 12.88B | 0.21% | 179,142 | 1.50B |
| 87 | FMS | Fresenius Medical Care AG | 12.54B | -0.75% | 626,107 | 22.19B |
| 88 | EXEL | Exelixis, Inc. | 12.51B | -1.64% | 1,865,524 | 2.44B |
| 89 | BTSG | BrightSpring Health Services, Inc. | 12.50B | 3.66% | 2,168,806 | 14.37B |
| 90 | SNN | Smith & Nephew plc | 12.42B | -0.53% | 633,730 | 6.30B |
| 91 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.40B | 0.31% | 218,468 | 1.28B |
| 92 | ALGN | Align Technology, Inc. | 12.38B | 0.78% | 357,280 | 4.14B |
| 93 | ARWR | Arrowhead Pharmaceuticals, Inc. | 12.35B | -2.03% | 661,816 | 669.50M |
| 94 | EHC | Encompass Health Corporation | 12.28B | -0.66% | 784,536 | 6.21B |
| 95 | CORT | Corcept Therapeutics Incorporated | 12.14B | 0.39% | 385,355 | 830.81M |
| 96 | SMMT | Summit Therapeutics Inc. | 11.98B | -0.66% | 2,894,442 | - |
| 97 | DVA | DaVita Inc. | 11.58B | 1.81% | 521,409 | 14.01B |
| 98 | HALO | Halozyme Therapeutics, Inc. | 11.57B | -0.64% | 2,258,273 | 1.66B |
| 99 | GMED | Globus Medical, Inc. | 11.49B | 0.47% | 674,791 | 3.14B |
| 100 | TECH | Bio-Techne Corporation | 11.27B | 0.26% | 1,871,666 | 1.22B |
| 101 | AXSM | Axsome Therapeutics, Inc. | 11.19B | -1.01% | 1,050,477 | 776.57M |
| 102 | ELAN | Elanco Animal Health Incorporated | 11.12B | -2.07% | 5,911,075 | 5.02B |
| 103 | ABVX | ABIVAX Société Anonyme | 10.94B | -1.05% | 405,357 | 5.67M |
| 104 | GKOS | Glaukos Corporation | 10.92B | 1.81% | 474,466 | 612.84M |
| 105 | PRAX | Praxis Precision Medicines, Inc. | 10.69B | 3.28% | 366,270 | 7.46M |
| 106 | MOH | Molina Healthcare, Inc. | 10.68B | 5.38% | 505,950 | 42.47B |
| 107 | CYTK | Cytokinetics, Incorporated | 10.53B | -0.93% | 1,144,447 | 67.67M |
| 108 | ENSG | The Ensign Group, Inc. | 10.49B | 0.72% | 155,754 | 5.49B |
| 109 | RDY | Dr. Reddy's Laboratories Limited | 10.47B | -0.52% | 1,445,650 | 3.50B |
| 110 | UHS | Universal Health Services, Inc. | 10.16B | 2.19% | 314,862 | 18.11B |
| 111 | APGE | Apogee Therapeutics, Inc. | 10.15B | -0.07% | 598,838 | - |
| 112 | HSIC | Henry Schein, Inc. | 10.11B | 1.73% | 717,089 | 13.60B |
| 113 | PODD | Insulet Corporation | 10.06B | 0.25% | 1,090,465 | 3.05B |
| 114 | KRYS | Krystal Biotech, Inc. | 9.85B | 1.80% | 120,104 | 440.48M |
| 115 | TEM | Tempus AI, Inc. | 9.81B | -2.39% | 2,679,842 | 1.43B |
| 116 | PTGX | Protagonist Therapeutics, Inc. | 9.80B | 2.10% | 290,456 | 281.99M |
| 117 | BIO | Bio-Rad Laboratories, Inc. | 9.64B | 1.18% | 148,205 | 2.59B |
| 118 | KYMR | Kymera Therapeutics, Inc. | 9.52B | 4.44% | 663,108 | 105.00M |
| 119 | RGEN | Repligen Corporation | 9.41B | 1.22% | 534,831 | 785.10M |
| 120 | IONS | Ionis Pharmaceuticals, Inc. | 9.39B | 2.00% | 1,440,547 | 874.09M |
| 121 | AVTR | Avantor, Inc. | 9.36B | 0.51% | 3,946,487 | 6.56B |
| 122 | OSCR | Oscar Health, Inc. | 9.25B | 7.26% | 5,001,408 | 15.32B |
| 123 | SYRE | Spyre Therapeutics, Inc. | 9.15B | 0.97% | 623,119 | - |
| 124 | BRKR | Bruker Corporation | 8.96B | 3.19% | 1,559,887 | 3.50B |
| 125 | CRNX | Crinetics Pharmaceuticals, Inc. | 8.96B | 0.17% | 1,879,906 | 42.16M |
| 126 | QGEN | Qiagen N.V. | 8.90B | 0.89% | 2,453,956 | 2.10B |
| 127 | PCVX | Vaxcyte, Inc. | 8.89B | 0.90% | 827,767 | - |
| 128 | HQY | HealthEquity, Inc. | 8.84B | 0.12% | 355,296 | 1.34B |
| 129 | IMVT | Immunovant, Inc. | 8.68B | 2.64% | 1,434,033 | - |
| 130 | ATR | AptarGroup, Inc. | 8.48B | -0.98% | 185,083 | 3.93B |
| 131 | ALKS | Alkermes plc | 8.41B | 1.87% | 641,931 | 1.67B |
| 132 | IBRX | ImmunityBio, Inc. | 8.20B | 1.78% | 4,311,827 | 165.79M |
| 133 | RYTM | Rhythm Pharmaceuticals, Inc. | 8.04B | 3.49% | 390,195 | 239.92M |
| 134 | TWST | Twist Bioscience Corporation | 7.74B | 0.26% | 966,273 | 431.80M |
| 135 | TXG | 10x Genomics, Inc. | 7.50B | -1.52% | 2,447,709 | 616.91M |
| 136 | PACS | PACS Group, Inc. | 7.21B | 1.33% | 388,857 | 5.55B |
| 137 | ORKA | Oruka Therapeutics, Inc. | 7.10B | 2.46% | 736,860 | - |
| 138 | CHE | Chemed Corporation | 7.07B | 1.14% | 86,605 | 2.60B |
| 139 | LQDA | Liquidia Corporation | 7.03B | -10.18% | 3,530,225 | 450.91M |
| 140 | TGTX | TG Therapeutics, Inc. | 7.02B | -0.77% | 1,384,341 | 799.54M |
| 141 | HNGE | Hinge Health, Inc. | 7.01B | -2.45% | 813,366 | 720.06M |
| 142 | BLTE | Belite Bio, Inc | 6.98B | -0.05% | 126,387 | - |
| 143 | HIMS | Hims & Hers Health, Inc. | 6.97B | -2.13% | 14,360,927 | 2.58B |
| 144 | GRFS | Grifols, S.A. | 6.96B | -0.50% | 188,382 | 8.48B |
| 145 | CGON | CG Oncology, Inc. | 6.77B | -0.80% | 406,565 | 6.23M |
| 146 | COGT | Cogent Biosciences, Inc. | 6.71B | -0.13% | 2,423,890 | - |
| 147 | LNTH | Lantheus Holdings, Inc. | 6.57B | 0.03% | 912,163 | 1.56B |
| 148 | SRRK | Scholar Rock Holding Corporation | 6.49B | 2.34% | 610,862 | - |
| 149 | ERAS | Erasca, Inc. | 6.47B | 0.96% | 2,552,237 | - |
| 150 | MIRM | Mirum Pharmaceuticals, Inc. | 6.43B | 0.78% | 499,189 | 618.07M |
| 151 | DNTH | Dianthus Therapeutics, Inc. | 6.33B | 4.33% | 466,712 | 1.90M |
| 152 | CAI | Caris Life Sciences, Inc. | 6.29B | -3.76% | 2,675,732 | 989.61M |
| 153 | XENE | Xenon Pharmaceuticals Inc. | 6.29B | 2.74% | 506,077 | 7.50M |
| 154 | KNSA | Kiniksa Pharmaceuticals International, plc | 6.10B | 0.45% | 426,347 | 840.85M |
| 155 | RDNT | RadNet, Inc. | 6.08B | 1.13% | 417,449 | 2.27B |
| 156 | PTCT | PTC Therapeutics, Inc. | 6.04B | -1.86% | 563,304 | 1.01B |
| 157 | BLCO | Bausch + Lomb Corporation | 6.00B | -0.41% | 294,163 | 5.32B |
| 158 | TVTX | Travere Therapeutics, Inc. | 5.86B | 3.29% | 709,108 | 591.33M |
| 159 | LGND | Ligand Pharmaceuticals Incorporated | 5.82B | 1.18% | 305,010 | 290.54M |
| 160 | MMED | MiniMed Group, Inc. | 5.81B | 4.55% | 1,020,855 | 3.10B |
| 161 | DFTX | Definium Therapeutics, Inc. | 5.80B | 5.52% | 6,872,075 | - |
| 162 | STVN | Stevanato Group S.p.A. | 5.79B | 0.76% | 488,909 | 1.40B |
| 163 | TFX | Teleflex Incorporated | 5.74B | 1.49% | 353,174 | 2.25B |
| 164 | AMRX | Amneal Pharmaceuticals, Inc. | 5.59B | 2.40% | 1,545,414 | 3.12B |
| 165 | MMSI | Merit Medical Systems, Inc. | 5.47B | 0.49% | 640,866 | 1.58B |
| 166 | SHC | Sotera Health Company | 5.38B | -1.36% | 1,403,043 | 1.22B |
| 167 | CRSP | CRISPR Therapeutics AG | 5.21B | -0.37% | 553,209 | 13.39M |
| 168 | ACAD | ACADIA Pharmaceuticals Inc. | 5.08B | 0.20% | 897,229 | 1.14B |
| 169 | DYN | Dyne Therapeutics, Inc. | 4.88B | -2.17% | 1,344,848 | - |
| 170 | EWTX | Edgewise Therapeutics, Inc. | 4.75B | -1.24% | 729,134 | - |
| 171 | PBLS | Parabilis Medicines, Inc. | 4.75B | 2.28% | 160,206 | - |
| 172 | WAY | Waystar Holding Corp. | 4.68B | 0.49% | 947,581 | 1.21B |
| 173 | LFST | LifeStance Health Group, Inc. | 4.65B | 5.83% | 3,902,573 | 1.58B |
| 174 | BLLN | BillionToOne, Inc. | 4.60B | -0.36% | 431,424 | 397.41M |
| 175 | NVST | Envista Holdings Corporation | 4.60B | 0.49% | 1,688,110 | 2.86B |
| 176 | INDV | Indivior Pharmaceuticals, Inc. | 4.57B | 0.70% | 1,803,760 | 1.33B |
| 177 | MANE | Veradermics, Incorporated | 4.52B | -0.79% | 1,128,411 | - |
| 178 | CELC | Celcuity Inc. | 4.48B | 4.33% | 584,838 | - |
| 179 | ICUI | ICU Medical, Inc. | 4.48B | -1.66% | 171,207 | 2.16B |
| 180 | DOCS | Doximity, Inc. | 4.47B | -4.02% | 3,265,148 | 655.57M |
| 181 | LIVN | LivaNova PLC | 4.45B | 2.76% | 677,956 | 1.47B |
| 182 | RLAY | Relay Therapeutics, Inc. | 4.40B | 0.55% | 1,206,875 | 10.35M |
| 183 | CON | Concentra Group Holdings Parent, Inc. | 4.38B | 3.97% | 652,156 | 2.29B |
| 184 | TNGX | Tango Therapeutics, Inc. | 4.33B | -2.54% | 1,738,602 | 53.81M |
| 185 | ITGR | Integer Holdings Corporation | 4.26B | 0.18% | 650,395 | 1.84B |
| 186 | ELVN | Enliven Therapeutics, Inc. | 4.25B | -1.29% | 837,845 | - |
| 187 | IRTC | iRhythm Holdings, Inc. | 4.14B | 3.13% | 781,793 | 825.34M |
| 188 | HAE | Haemonetics Corporation | 4.12B | 3.88% | 498,979 | 1.35B |
| 189 | TLX | Telix Pharmaceuticals Limited | 4.06B | -0.08% | 65,669 | 803.79M |
| 190 | DNLI | Denali Therapeutics Inc. | 4.02B | 1.78% | 1,024,613 | 3.60M |
| 191 | ADPT | Adaptive Biotechnologies Corporation | 4.01B | -1.10% | 884,563 | 308.08M |
| 192 | LEGN | Legend Biotech Corporation | 3.99B | -5.50% | 2,771,131 | 1.27B |
| 193 | VKTX | Viking Therapeutics, Inc. | 3.93B | -0.24% | 1,028,044 | - |
| 194 | GPCR | Structure Therapeutics Inc. | 3.80B | 2.13% | 1,348,386 | - |
| 195 | RCUS | Arcus Biosciences, Inc. | 3.67B | 0.28% | 616,070 | 117.00M |
| 196 | OGN | Organon & Co. | 3.59B | 0.04% | 4,765,634 | 6.13B |
| 197 | VCYT | Veracyte, Inc. | 3.58B | -4.01% | 536,670 | 561.90M |
| 198 | OPCH | Option Care Health, Inc. | 3.57B | -1.12% | 965,638 | 5.69B |
| 199 | IDYA | IDEAYA Biosciences, Inc. | 3.55B | -0.11% | 265,683 | 234.13M |
| 200 | CLDX | Celldex Therapeutics, Inc. | 3.51B | 0.88% | 1,343,013 | 158.00K |
| 201 | NHC | National HealthCare Corporation | 3.43B | 1.17% | 110,842 | 1.56B |
| 202 | NAMS | NewAmsterdam Pharma Company N.V. | 3.33B | 0.94% | 1,310,656 | 7.12M |
| 203 | ARQT | Arcutis Biotherapeutics, Inc. | 3.29B | -0.13% | 769,370 | 463.98M |
| 204 | ALMS | Alumis Inc. | 3.24B | 0.28% | 699,248 | 8.40M |
| 205 | MBX | MBX Biosciences, Inc. | 3.23B | 1.47% | 213,108 | - |
| 206 | IMNM | Immunome, Inc. | 3.15B | 5.71% | 1,158,965 | 4.02M |
| 207 | ABCL | AbCellera Biologics Inc. | 3.14B | 5.07% | 12,776,078 | 66.17M |
| 208 | WRBY | Warby Parker Inc. | 3.13B | 1.12% | 1,553,659 | 911.61M |
| 209 | QURE | uniQure N.V. | 3.12B | - | 554,313 | 18.67M |
| 210 | BKD | Brookdale Senior Living Inc. | 3.12B | 3.98% | 5,459,822 | 2.93B |
| 211 | IRON | Disc Medicine, Inc. | 3.09B | -1.02% | 189,886 | - |
| 212 | PLSE | Pulse Biosciences, Inc. | 3.08B | -2.59% | 255,954 | 1.19M |
| 213 | GRAL | GRAIL, Inc. | 3.08B | -8.64% | 404,077 | 165.26M |
| 214 | TARS | Tarsus Pharmaceuticals, Inc. | 3.06B | 0.36% | 704,085 | 606.33M |
| 215 | TMDX | TransMedics Group, Inc. | 3.04B | -1.76% | 498,994 | 668.47M |
| 216 | IOVA | Iovance Biotherapeutics, Inc. | 3.00B | 2.08% | 10,375,609 | 324.97M |
| 217 | ACHC | Acadia Healthcare Company, Inc. | 2.98B | 3.02% | 773,266 | 3.37B |
| 218 | ZLAB | Zai Lab Limited | 2.85B | -2.58% | 1,669,122 | 449.61M |
| 219 | ALHC | Alignment Healthcare, Inc. | 2.78B | 1.67% | 2,525,475 | 4.58B |
| 220 | NRIX | Nurix Therapeutics, Inc. | 2.77B | 2.66% | 621,392 | 36.77M |
| 221 | PRVA | Privia Health Group, Inc. | 2.76B | -1.59% | 1,375,532 | 2.36B |
| 222 | SUPN | Supernus Pharmaceuticals, Inc. | 2.76B | 1.26% | 449,614 | 830.44M |
| 223 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.70B | 2.22% | 2,826,651 | 940.61M |
| 224 | KOD | Kodiak Sciences Inc. | 2.69B | 2.16% | 266,286 | - |
| 225 | AXGN | Axogen, Inc. | 2.68B | 2.85% | 532,898 | 251.17M |
| 226 | ATAI | AtaiBeckley Inc. | 2.68B | 0.21% | 3,118,026 | 4.47M |
| 227 | BEAM | Beam Therapeutics Inc. | 2.67B | -0.52% | 783,416 | 156.04M |
| 228 | RARE | Ultragenyx Pharmaceutical Inc. | 2.64B | -0.48% | 797,440 | 717.00M |
| 229 | AMLX | Amylyx Pharmaceuticals, Inc. | 2.61B | -0.89% | 1,133,515 | -665.00K |
| 230 | HTFL | HeartFlow, Inc. | 2.59B | 1.52% | 773,892 | 191.42M |
| 231 | VRDN | Viridian Therapeutics, Inc. | 2.58B | -0.87% | 1,153,682 | 71.13M |
| 232 | NKTR | Nektar Therapeutics | 2.57B | 0.83% | 329,577 | 55.63M |
| 233 | RGC | Regencell Bioscience Holdings Limited | 2.54B | 2.19% | 157,588 | - |
| 234 | PHVS | Pharvaris N.V. | 2.52B | 4.82% | 1,038,434 | - |
| 235 | UFPT | UFP Technologies, Inc. | 2.52B | 1.11% | 104,014 | 631.64M |
| 236 | TRVI | Trevi Therapeutics, Inc. | 2.51B | -0.90% | 823,690 | - |
| 237 | NEOG | Neogen Corporation | 2.50B | -0.17% | 687,083 | 870.40M |
| 238 | PBH | Prestige Consumer Healthcare Inc. | 2.50B | -1.66% | 378,381 | 1.10B |
| 239 | BFLY | Butterfly Network, Inc. | 2.49B | -0.16% | 2,589,902 | 112.14M |
| 240 | WGS | GeneDx Holdings Corp. | 2.46B | 0.77% | 382,302 | 454.43M |
| 241 | COAG | Hemab Therapeutics Holdings, Inc. | 2.45B | 1.43% | 216,256 | - |
| 242 | GRDN | Guardian Pharmacy Services, Inc. | 2.45B | -2.10% | 227,176 | 1.46B |
| 243 | CDNA | CareDx, Inc. | 2.44B | -0.06% | 505,318 | 458.09M |
| 244 | PGEN | Precigen, Inc. | 2.44B | -0.66% | 3,538,356 | 85.72M |
| 245 | KLRA | Kailera Therapeutics, Inc. | 2.40B | -1.80% | 154,718 | - |
| 246 | CLOV | Clover Health Investments, Corp. | 2.40B | 2.85% | 3,782,051 | 2.48B |
| 247 | URGN | UroGen Pharma Ltd. | 2.39B | 3.71% | 1,234,773 | 188.73M |
| 248 | MLYS | Mineralys Therapeutics, Inc. | 2.38B | -1.21% | 1,010,864 | - |
| 249 | SLS | SELLAS Life Sciences Group, Inc. | 2.35B | 5.38% | 7,177,316 | - |
| 250 | ALMR | Alamar Biosciences, Inc. | 2.34B | -7.60% | 437,854 | 100.42M |
| 251 | BHC | Bausch Health Companies Inc. | 2.31B | -0.96% | 1,728,856 | 10.85B |
| 252 | HRMY | Harmony Biosciences Holdings, Inc. | 2.30B | -0.03% | 406,210 | 959.90M |
| 253 | RAPP | Rapport Therapeutics, Inc. | 2.29B | -2.15% | 227,498 | 20.00M |
| 254 | VCEL | Vericel Corporation | 2.29B | 0.79% | 186,808 | 306.30M |
| 255 | XRAY | DENTSPLY SIRONA Inc. | 2.26B | -2.45% | 5,101,591 | 3.64B |
| 256 | ESTA | Establishment Labs Holdings Inc. | 2.25B | 1.82% | 317,793 | 245.82M |
| 257 | NUVB | Nuvation Bio Inc. | 2.25B | 0.71% | 1,871,022 | 169.90M |
| 258 | PVLA | Palvella Therapeutics, Inc. | 2.24B | 0.84% | 134,900 | - |
| 259 | SEPN | Septerna, Inc. | 2.24B | 0.40% | 906,997 | 98.88M |
| 260 | OCUL | Ocular Therapeutix, Inc. | 2.23B | 3.89% | 3,480,163 | 52.06M |
| 261 | ATRC | AtriCure, Inc. | 2.23B | 1.89% | 276,554 | 569.62M |
| 262 | MESO | Mesoblast Limited | 2.20B | -1.06% | 117,679 | 65.38M |
| 263 | ADMA | ADMA Biologics, Inc. | 2.19B | -1.21% | 1,196,334 | 512.28M |
| 264 | ADUS | Addus HomeCare Corporation | 2.16B | 1.16% | 135,206 | 1.48B |
| 265 | BHVN | Biohaven Ltd. | 2.16B | -1.31% | 1,388,269 | - |
| 266 | HCM | HUTCHMED (China) Limited | 2.15B | -1.14% | 24,499 | 549.12M |
| 267 | VERA | Vera Therapeutics, Inc. | 2.15B | -1.65% | 928,015 | - |
| 268 | STOK | Stoke Therapeutics, Inc. | 2.13B | 0.12% | 787,371 | 27.59M |
| 269 | NEO | NeoGenomics, Inc. | 2.11B | -0.42% | 635,754 | 766.30M |
| 270 | MD | Pediatrix Medical Group, Inc. | 2.10B | 1.28% | 386,689 | 1.95B |
| 271 | TSHA | Taysha Gene Therapies, Inc. | 2.06B | -5.24% | 2,808,012 | 5.49M |
| 272 | AUPH | Aurinia Pharmaceuticals Inc. | 2.06B | 0.52% | 637,609 | 311.51M |
| 273 | GHRS | GH Research PLC | 2.05B | 2.75% | 1,063,391 | - |
| 274 | AGIO | Agios Pharmaceuticals, Inc. | 2.03B | 4.25% | 737,756 | 98.34M |
| 275 | NVCR | NovoCure Limited | 2.02B | -1.64% | 420,255 | 699.19M |
| 276 | ZBIO | Zenas BioPharma, Inc. | 2.01B | -1.85% | 289,689 | 10.00M |
| 277 | SGRY | Surgery Partners, Inc. | 1.99B | 2.47% | 2,991,502 | 3.37B |
| 278 | AVAH | Aveanna Healthcare Holdings Inc. | 1.98B | 1.68% | 2,384,192 | 2.52B |
| 279 | PGNY | Progyny, Inc. | 1.96B | -3.95% | 1,001,326 | 1.31B |
| 280 | NBTX | Nanobiotix S.A. | 1.95B | 2.30% | 177,206 | 38.27M |
| 281 | GENB | Generate Biomedicines, Inc. | 1.95B | 6.59% | 662,814 | 26.48M |
| 282 | SRPT | Sarepta Therapeutics, Inc. | 1.94B | 0.66% | 1,670,093 | 1.97B |
| 283 | DMRA | Damora Therapeutics, Inc. | 1.92B | 2.40% | 217,131 | - |
| 284 | KARD | Kardigan, Inc. | 1.90B | -3.40% | 203,036 | - |
| 285 | CMPS | COMPASS Pathways plc | 1.90B | 5.08% | 3,639,478 | - |
| 286 | FBRX | Forte Biosciences, Inc. | 1.88B | -0.09% | 1,215,269 | - |
| 287 | LMAT | LeMaitre Vascular, Inc. | 1.87B | -1.53% | 223,876 | 262.43M |
| 288 | LKFT | Lakefront Biotherapeutics NV | 1.86B | -2.85% | 327,102 | 1.13B |
| 289 | SNDA | Sonida Senior Living, Inc. | 1.86B | 0.75% | 354,723 | 481.07M |
| 290 | ASTH | Astrana Health, Inc. | 1.83B | 3.71% | 301,143 | 3.84B |
| 291 | IMCR | Immunocore Holdings plc | 1.78B | 1.17% | 276,440 | 430.78M |
| 292 | ZYME | Zymeworks Inc. | 1.77B | 2.67% | 378,649 | 37.13M |
| 293 | TRLV | Trulieve Cannabis Corp. | 1.76B | -1.61% | 318,677 | 1.14B |
| 294 | SNDX | Syndax Pharmaceuticals, Inc. | 1.76B | -2.76% | 634,359 | 252.25M |
| 295 | FTRE | Fortrea Holdings Inc. | 1.76B | -5.10% | 1,181,505 | 2.68B |
| 296 | RXRX | Recursion Pharmaceuticals, Inc. | 1.76B | -1.94% | 8,888,212 | 54.86M |
| 297 | PRGO | Perrigo Company plc | 1.75B | -2.14% | 1,461,713 | 4.14B |
| 298 | BLFS | BioLife Solutions, Inc. | 1.72B | 0.92% | 273,388 | 106.69M |
| 299 | XNCR | Xencor, Inc. | 1.71B | 4.34% | 717,804 | 104.97M |
| 300 | AAPG | Ascentage Pharma Group International | 1.71B | -0.05% | 2,491 | 82.08M |
| 301 | OMCL | Omnicell, Inc. | 1.69B | 0.60% | 423,203 | 1.25B |
| 302 | INSP | Inspire Medical Systems, Inc. | 1.69B | -1.20% | 409,142 | 898.74M |
| 303 | ANAB | AnaptysBio, Inc. | 1.69B | -1.49% | 258,022 | 232.39M |
| 304 | NTLA | Intellia Therapeutics, Inc. | 1.69B | 0.08% | 1,580,182 | 59.51M |
| 305 | BRVE | Braveheart Bio, Inc. | 1.68B | 4.40% | 544,866 | - |
| 306 | AVLN | Avalyn Pharma Inc. | 1.66B | 5.75% | 337,096 | - |
| 307 | KMTS | Kestra Medical Technologies, Ltd. | 1.65B | 0.68% | 270,862 | 95.13M |
| 308 | TNDM | Tandem Diabetes Care, Inc. | 1.63B | 0.04% | 1,205,055 | 1.04B |
| 309 | BCAX | Bicara Therapeutics Inc. | 1.63B | 3.62% | 596,362 | - |
| 310 | TRAX | First Tracks Biotherapeutics, Inc. | 1.62B | -0.59% | 226,165 | - |
| 311 | ANIP | ANI Pharmaceuticals, Inc. | 1.60B | 0.44% | 371,439 | 978.38M |
| 312 | ABSI | Absci Corporation | 1.60B | -0.96% | 3,177,586 | 1.56M |
| 313 | ARDT | Ardent Health, Inc. | 1.56B | 0.55% | 145,630 | 6.41B |
| 314 | XERS | Xeris Biopharma Holdings, Inc. | 1.55B | 1.07% | 1,291,746 | 335.41M |
| 315 | MAZE | Maze Therapeutics, Inc. | 1.52B | 0.48% | 315,424 | 20.00M |
| 316 | PSNL | Personalis, Inc. | 1.52B | 1.71% | 1,256,733 | 69.67M |
| 317 | VIR | Vir Biotechnology, Inc. | 1.51B | - | 542,795 | 303.23M |
| 318 | INVA | Innoviva, Inc. | 1.50B | 0.34% | 391,542 | 440.00M |
| 319 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.50B | -0.52% | 996,912 | 208.78M |
| 320 | TYRA | Tyra Biosciences, Inc. | 1.50B | -0.24% | 318,009 | - |
| 321 | ATEC | Alphatec Holdings, Inc. | 1.49B | 2.93% | 1,184,552 | 815.05M |
| 322 | CNMD | CONMED Corporation | 1.49B | 0.26% | 125,190 | 1.37B |
| 323 | AGL | agilon health, inc. | 1.49B | 2.58% | 292,562 | 5.92B |
| 324 | HROW | Harrow, Inc. | 1.48B | 0.23% | 609,694 | 275.59M |
| 325 | LBRX | LB Pharmaceuticals Inc | 1.47B | 0.62% | 236,092 | - |
| 326 | JBIO | Jade Biosciences, Inc. | 1.47B | 3.36% | 564,089 | - |
| 327 | AZTA | Azenta, Inc. | 1.47B | 0.39% | 353,215 | 613.81M |
| 328 | MLTX | MoonLake Immunotherapeutics | 1.47B | 3.98% | 2,471,280 | - |
| 329 | OMDA | Omada Health, Inc. | 1.46B | -0.37% | 1,243,842 | 309.76M |
| 330 | AVBP | ArriVent BioPharma, Inc. | 1.46B | 0.13% | 191,504 | - |
| 331 | ORIC | ORIC Pharmaceuticals, Inc. | 1.44B | 1.38% | 588,951 | - |
| 332 | SVRA | Savara Inc. | 1.44B | 1.62% | 858,359 | - |
| 333 | HCSG | Healthcare Services Group, Inc. | 1.44B | -0.19% | 622,265 | 1.86B |
| 334 | INBX | Inhibrx Biosciences, Inc. | 1.43B | 5.41% | 121,808 | 1.30M |
| 335 | INNV | InnovAge Holding Corp. | 1.42B | 2.25% | 104,305 | 949.17M |
| 336 | REPL | Replimune Group, Inc. | 1.42B | 10.62% | 5,960,549 | - |
| 337 | AORT | Artivion, Inc. | 1.41B | 2.15% | 533,083 | 471.47M |
| 338 | ENOV | Enovis Corporation | 1.41B | -0.41% | 443,144 | 2.30B |
| 339 | ALVO | Alvotech | 1.41B | 3.95% | 770,619 | 562.04M |
| 340 | SDGR | Schrödinger, Inc. | 1.40B | - | 621,760 | 259.04M |
| 341 | PAHC | Phibro Animal Health Corporation | 1.37B | -0.89% | 82,833 | 1.50B |
| 342 | GLUE | Monte Rosa Therapeutics, Inc. | 1.37B | 1.59% | 426,559 | 28.73M |
| 343 | IART | Integra LifeSciences Holdings Corporation | 1.35B | 0.17% | 269,827 | 1.65B |
| 344 | PNTG | The Pennant Group, Inc. | 1.34B | 0.34% | 200,104 | 1.10B |
| 345 | AKTS | Aktis Oncology, Inc. | 1.33B | -2.62% | 153,618 | 8.28M |
| 346 | VOR | Vor Biopharma Inc. | 1.32B | -5.26% | 769,535 | - |
| 347 | IMTX | Immatics N.V. | 1.32B | -1.03% | 134,153 | 43.00M |
| 348 | NVAX | Novavax, Inc. | 1.30B | -0.50% | 1,546,903 | 413.80M |
| 349 | FRNM | Freenome, Inc. | 1.30B | -4.08% | 1,311,000 | 34.24M |
| 350 | STAA | STAAR Surgical Company | 1.29B | 4.09% | 817,301 | 290.38M |
| 351 | DRTS | Alpha Tau Medical Ltd. | 1.29B | -2.17% | 427,254 | - |
| 352 | AMN | AMN Healthcare Services, Inc. | 1.27B | -1.18% | 630,397 | 3.43B |
| 353 | CRVS | Corvus Pharmaceuticals, Inc. | 1.27B | 2.10% | 689,858 | - |
| 354 | SPTX | Seaport Therapeutics, Inc. | 1.26B | 1.03% | 176,233 | - |
| 355 | CGEM | Cullinan Therapeutics, Inc. | 1.26B | -0.36% | 446,830 | - |
| 356 | MNKD | MannKind Corporation | 1.23B | - | 2,334,704 | 393.63M |
| 357 | LTGO | Latigo Biotherapeutics, Inc. | 1.23B | 4.75% | 187,561 | - |
| 358 | CERT | Certara, Inc. | 1.22B | -1.23% | 1,273,075 | 421.75M |
| 359 | USPH | U.S. Physical Therapy, Inc. | 1.22B | 0.27% | 77,413 | 804.27M |
| 360 | GDRX | GoodRx Holdings, Inc. | 1.22B | -5.79% | 1,320,558 | 785.23M |
| 361 | PRCT | PROCEPT BioRobotics Corporation | 1.21B | -7.45% | 793,558 | 337.34M |
| 362 | TDOC | Teladoc Health, Inc. | 1.21B | -2.35% | 2,556,077 | 2.49B |
| 363 | MGTX | MeiraGTx Holdings plc | 1.20B | -0.38% | 179,969 | 79.76M |
| 364 | NUTX | Nutex Health Inc. | 1.18B | 3.62% | 148,464 | 846.72M |
| 365 | BVS | Bioventus Inc. | 1.17B | 0.58% | 385,661 | 581.85M |
| 366 | EYPT | EyePoint, Inc. | 1.17B | 4.06% | 1,665,007 | 2.79M |
| 367 | OBX | Obsidian Therapeutics, Inc. | 1.17B | -17.94% | 109,906 | - |
| 368 | ETON | Eton Pharmaceuticals, Inc. | 1.17B | 1.31% | 270,944 | 86.93M |
| 369 | AHG | Akso Health Group | 1.16B | -2.88% | 805 | 13.83M |
| 370 | SANA | Sana Biotechnology, Inc. | 1.14B | 0.79% | 1,231,011 | - |
| 371 | CRON | Cronos Group Inc. | 1.14B | 2.76% | 1,820,444 | 179.09M |
| 372 | LMRI | Lumexa Imaging Holdings, Inc. | 1.13B | 0.94% | 541,672 | 1.03B |
| 373 | ANRO | Alto Neuroscience, Inc. | 1.13B | 0.80% | 198,802 | - |
| 374 | IVA | Inventiva S.A. | 1.12B | - | 353,122 | 7.94M |
| 375 | IRMD | IRADIMED CORPORATION | 1.12B | -1.21% | 151,369 | 86.34M |
| 376 | LXRX | Lexicon Pharmaceuticals, Inc. | 1.06B | -2.06% | 2,077,995 | 41.47M |
| 377 | AVTX | Avalo Therapeutics, Inc. | 1.05B | 0.26% | 186,572 | 59.00K |
| 378 | OPK | OPKO Health, Inc. | 1.04B | 0.36% | 1,215,345 | 587.90M |
| 379 | ODTX | Odyssey Therapeutics, Inc. | 1.04B | 6.44% | 63,148 | 99.00K |
| 380 | WVE | Wave Life Sciences Ltd. | 1.02B | 3.07% | 3,517,852 | 65.37M |
| 381 | APMD | Apnimed, Inc. | 1.02B | 2.73% | 223,466 | 120.15M |
| 382 | JANX | Janux Therapeutics, Inc. | 1.02B | 0.67% | 477,861 | 24.00M |
| 383 | GERN | Geron Corporation | 1.01B | -3.37% | 8,343,287 | 204.56M |
| 384 | QDEL | QuidelOrtho Corporation | 1.01B | 5.43% | 1,308,404 | 2.67B |
| 385 | OMER | Omeros Corporation | 994.44M | 1.03% | 1,632,625 | 9.89M |
| 386 | ARDX | Ardelyx, Inc. | 984.29M | 0.25% | 3,595,642 | 450.89M |
| 387 | GMRS | GMR Solutions Inc. | 970.62M | 4.96% | 2,258,803 | 5.83B |
| 388 | SLDB | Solid Biosciences Inc. | 962.88M | 1.47% | 539,164 | - |
| 389 | CSTL | Castle Biosciences, Inc. | 955.89M | -2.95% | 235,416 | 357.28M |
| 390 | PCRX | Pacira BioSciences, Inc. | 942.93M | -2.97% | 368,640 | 746.16M |
| 391 | GLAS | Glass House Brands Inc. | 924.63M | 3.31% | 253,736 | 177.68M |
| 392 | DSGN | Design Therapeutics, Inc. | 914.32M | -0.07% | 181,591 | - |
| 393 | OLMA | Olema Pharmaceuticals, Inc. | 904.73M | -0.86% | 931,456 | - |
| 394 | ABUS | Arbutus Biopharma Corporation | 901.76M | -2.25% | 1,145,753 | 181.72M |
| 395 | TBPH | Theravance Biopharma, Inc. | 878.47M | - | 287,894 | 104.31M |
| 396 | INMD | InMode Ltd. | 877.73M | 0.86% | 241,684 | 374.63M |
| 397 | ANNX | Annexon, Inc. | 873.28M | -0.19% | 3,055,668 | - |
| 398 | CBLL | CeriBell, Inc. | 873.10M | 6.76% | 392,256 | 101.96M |
| 399 | TALK | Talkspace, Inc. | 870.58M | 0.19% | 844,015 | 245.73M |
| 400 | KURA | Kura Oncology, Inc. | 869.99M | -1.31% | 729,143 | 71.64M |
| 401 | AVR | Anteris Technologies Global Corp. | 869.79M | -2.67% | 615,547 | 2.24M |
| 402 | ACRS | Aclaris Therapeutics, Inc. | 867.00M | -0.51% | 619,739 | 8.22M |
| 403 | SIBN | SI-BONE, Inc. | 855.59M | 1.54% | 219,301 | 213.60M |
| 404 | AMPH | Amphastar Pharmaceuticals, Inc. | 852.46M | -1.86% | 233,594 | 730.02M |
| 405 | SGP | SpyGlass Pharma, Inc. | 839.21M | 0.97% | 49,194 | - |
| 406 | COLL | Collegium Pharmaceutical, Inc. | 838.31M | -0.89% | 767,628 | 808.21M |
| 407 | DBVT | DBV Technologies S.A. | 834.54M | 0.99% | 120,930 | 5.04M |
| 408 | HSTM | HealthStream, Inc. | 830.12M | 0.11% | 131,818 | 321.12M |
| 409 | PHAR | Pharming Group N.V. | 820.19M | -4.33% | 35,839 | 366.48M |
| 410 | CLYM | Climb Bio, Inc. | 817.89M | 2.82% | 879,221 | - |
| 411 | IMMX | Immix Biopharma, Inc. | 800.52M | -2.61% | 1,213,962 | - |
| 412 | OCS | Oculis Holding AG | 796.96M | 1.25% | 207,871 | 1.45M |
| 413 | AURA | Aura Biosciences, Inc. | 794.38M | -4.73% | 742,139 | - |
| 414 | DRUG | Bright Minds Biosciences Inc. | 792.01M | -0.19% | 97,794 | - |
| 415 | BBNX | Beta Bionics, Inc. | 781.92M | -1.36% | 475,503 | 119.01M |
| 416 | VREX | Varex Imaging Corporation | 778.47M | -0.59% | 1,748,254 | 865.00M |
| 417 | RIGL | Rigel Pharmaceuticals, Inc. | 777.83M | -0.90% | 156,274 | 276.79M |
| 418 | FTH | Faeth Therapeutics, Inc. | 777.54M | 0.30% | 247,539 | - |
| 419 | CADL | Candel Therapeutics, Inc. | 775.93M | -0.56% | 1,217,693 | - |
| 420 | AHCO | AdaptHealth Corp. | 775.11M | 2.83% | 3,159,480 | 3.36B |
| 421 | ATTO | Attovia Therapeutics, Inc. | 768.07M | -4.29% | 537,887 | 1.35M |
| 422 | MNPR | Monopar Therapeutics Inc. | 767.41M | 0.09% | 316,984 | - |
| 423 | EVO | Evotec SE | 760.14M | 4.76% | 45,902 | 859.03M |
| 424 | CTMX | CytomX Therapeutics, Inc. | 755.02M | 0.43% | 1,068,847 | 18.30M |
| 425 | SSII | SS Innovations International, Inc. | 754.50M | 4.43% | 15,017 | 48.47M |
| 426 | PHR | Phreesia, Inc. | 749.16M | -1.22% | 249,995 | 495.59M |
| 427 | STTK | Shattuck Labs, Inc. | 746.70M | 3.62% | 1,058,004 | 1.00M |
| 428 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 746.20M | 1.25% | 97,794 | - |
| 429 | NGNE | Neurogene Inc. | 734.02M | 2.46% | 237,395 | 925.00K |
| 430 | IRWD | Ironwood Pharmaceuticals, Inc. | 730.36M | 2.79% | 2,084,984 | 389.32M |
| 431 | PHAT | Phathom Pharmaceuticals, Inc. | 726.79M | 7.52% | 1,521,545 | 239.66M |
| 432 | RGNX | REGENXBIO Inc. | 724.82M | 3.10% | 582,517 | 174.48M |
| 433 | ALLO | Allogene Therapeutics, Inc. | 712.74M | -2.59% | 3,472,075 | 22.00K |
| 434 | TECX | Tectonic Therapeutic, Inc. | 712.38M | 14.34% | 577,884 | - |
| 435 | GYRE | Gyre Therapeutics, Inc. | 710.96M | 0.98% | 79,102 | 109.82M |
| 436 | CBIO | Crescent Biopharma, Inc. | 704.08M | -1.44% | 145,461 | 11.88M |
| 437 | HELP | Cybin Inc. | 700.42M | 11.99% | 2,978,312 | - |
| 438 | AGMB | AgomAb Therapeutics NV | 689.96M | -5.66% | 141,962 | - |
| 439 | ACHV | Achieve Life Sciences, Inc. | 688.42M | -1.18% | 1,161,168 | - |
| 440 | ZVRA | Zevra Therapeutics, Inc. | 681.13M | 1.15% | 433,034 | 136.07M |
| 441 | ANGO | AngioDynamics, Inc. | 652.43M | 0.22% | 495,876 | 320.17M |
| 442 | KIDS | OrthoPediatrics Corp. | 649.35M | 2.60% | 201,433 | 252.72M |
| 443 | STLN | Starling Oncology, Inc. | 646.15M | 2.34% | 931,759 | 587.24M |
| 444 | SLN | Silence Therapeutics plc | 645.22M | -7.20% | 4,640,198 | 615.00K |
| 445 | TLRY | Tilray Brands, Inc. | 638.74M | -1.46% | 2,506,386 | 915.45M |
| 446 | SOPH | SOPHiA GENETICS SA | 638.46M | -1.45% | 271,599 | 86.17M |
| 447 | NVCT | Nuvectis Pharma, Inc. | 635.99M | 0.57% | 47,173 | - |
| 448 | BWAY | BrainsWay Ltd. | 631.83M | 12.08% | 511,557 | 60.70M |
| 449 | MDXG | MiMedx Group, Inc. | 625.31M | -0.69% | 500,839 | 355.17M |
| 450 | VSTM | Verastem, Inc. | 624.89M | -2.13% | 777,743 | 87.53M |
| 451 | CTKB | Cytek Biosciences, Inc. | 618.72M | 0.42% | 565,608 | 206.71M |
| 452 | FDMT | 4D Molecular Therapeutics, Inc. | 610.59M | 1.83% | 289,838 | 88.24M |
| 453 | SPRY | ARS Pharmaceuticals, Inc. | 599.79M | 1.51% | 1,001,692 | 98.99M |
| 454 | DCTH | Delcath Systems, Inc. | 593.35M | -0.70% | 549,371 | 95.42M |
| 455 | CTEV | Claritev Corporation | 592.31M | -0.03% | 97,197 | 994.67M |
| 456 | PRLD | Prelude Therapeutics Incorporated | 592.22M | 8.08% | 565,432 | 22.42M |
| 457 | SGMT | Sagimet Biosciences Inc. | 589.89M | -0.32% | 848,288 | - |
| 458 | ARVN | Arvinas, Inc. | 581.28M | -1.11% | 346,408 | 316.70M |
| 459 | PRME | Prime Medicine, Inc. | 571.07M | -1.53% | 1,073,685 | 4.07M |
| 460 | ARTV | Artiva Biotherapeutics, Inc. | 570.55M | -0.93% | 212,857 | 251.00K |
| 461 | ALT | Altimmune, Inc. | 569.81M | -2.33% | 5,023,188 | 31.00K |
| 462 | EIKN | Eikon Therapeutics, Inc. | 560.88M | 1.27% | 299,570 | - |
| 463 | CRMD | CorMedix Inc. | 560.15M | -2.19% | 974,680 | 400.05M |
| 464 | AUTL | Autolus Therapeutics plc | 558.90M | -9.87% | 3,389,164 | 117.39M |
| 465 | CTNM | Contineum Therapeutics, Inc. | 557.92M | 0.07% | 835,386 | - |
| 466 | ZURA | Zura Bio Limited | 557.73M | 4.68% | 1,095,666 | - |
| 467 | TCMD | Tactile Systems Technology, Inc. | 549.09M | 0.37% | 425,580 | 350.31M |
| 468 | CERS | Cerus Corporation | 544.12M | 5.26% | 2,014,736 | 221.55M |
| 469 | VALN | Valneva SE | 538.47M | -1.07% | 65,246 | 180.25M |
| 470 | AQST | Aquestive Therapeutics, Inc. | 535.93M | -3.17% | 8,291,198 | 54.09M |
| 471 | EOLS | Evolus, Inc. | 535.67M | -2.76% | 710,203 | 316.49M |
| 472 | SRTA | Strata Critical Medical, Inc. | 531.69M | -0.33% | 522,190 | 255.98M |
| 473 | MPLT | MapLight Therapeutics, Inc. | 531.00M | -2.25% | 274,104 | - |
| 474 | ANL | Adlai Nortye Ltd. | 525.80M | 0.50% | 104,826 | 5.00M |
| 475 | ASMB | Assembly Biosciences, Inc. | 520.93M | -0.77% | 88,990 | 71.10M |
| 476 | FLGT | Fulgent Genetics, Inc. | 517.29M | -1.05% | 97,505 | 323.93M |
| 477 | EVMN | Evommune, Inc. | 511.72M | -0.77% | 520,114 | 10.00M |
| 478 | NPCE | NeuroPace, Inc. | 509.54M | -1.36% | 133,960 | 106.99M |
| 479 | RLMD | Relmada Therapeutics, Inc. | 507.22M | 6.38% | 1,179,180 | - |
| 480 | MCTA | Charming Medical Limited | 504.26M | -0.83% | - | 4.81M |
| 481 | OABI | OmniAb, Inc. | 500.14M | 1.78% | 673,650 | 38.46M |
| 482 | BLSM | BlossomHill Therapeutics, Inc. | 498.88M | -1.45% | 368,567 | - |
| 483 | DNA | Ginkgo Bioworks Holdings, Inc. | 489.56M | -3.20% | 714,204 | 132.42M |
| 484 | RZLT | Rezolute, Inc. | 488.90M | 1.30% | 644,867 | - |
| 485 | OVID | Ovid Therapeutics Inc. | 487.13M | 1.16% | 752,504 | 7.12M |
| 486 | KYTX | Kyverna Therapeutics, Inc. | 486.36M | -0.25% | 899,664 | - |
| 487 | BIOA | BioAge Labs, Inc. | 483.75M | -1.22% | 448,199 | 10.36M |
| 488 | ENTX | Entera Bio Ltd. | 481.33M | -7.33% | 335,470 | 42.00K |
| 489 | EVH | Evolent Health, Inc. | 475.41M | 2.56% | 2,817,807 | 2.10B |
| 490 | OCGN | Ocugen, Inc. | 473.06M | 1.82% | 2,403,673 | 4.58M |
| 491 | PRTA | Prothena Corporation plc | 472.81M | -0.11% | 154,352 | 54.53M |
| 492 | IKT | Inhibikase Therapeutics, Inc. | 470.97M | -1.63% | 204,609 | 1.00 |
| 493 | CLPT | ClearPoint Neuro, Inc. | 466.71M | 2.68% | 423,246 | 42.28M |
| 494 | CABA | Cabaletta Bio, Inc. | 461.45M | 1.43% | 2,442,587 | - |
| 495 | NRC | NRC Health | 458.32M | -3.09% | 119,129 | 140.00M |
| 496 | QTTB | Q32 Bio Inc. | 456.96M | -0.39% | 198,791 | 53.74M |
| 497 | PBYI | Puma Biotechnology, Inc. | 456.32M | 0.80% | 302,620 | 231.24M |
| 498 | SGHT | Sight Sciences, Inc. | 456.13M | 6.84% | 433,020 | 83.38M |
| 499 | LRMR | Larimar Therapeutics, Inc. | 453.02M | 0.70% | 845,656 | - |
| 500 | PROK | ProKidney Corp. | 442.90M | -9.01% | 2,290,098 | 818.00K |